Acorah Software Products - Accounts Production 19.4.351 false true false true No description of principal activity 7 November 2025 31 March 2026 31 March 2026 16840429 Miss Zeba Jabeen iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16840429 2025-11-06 16840429 2026-03-31 16840429 2025-11-07 2026-03-31 16840429 frs-core:CurrentFinancialInstruments 2026-03-31 16840429 frs-bus:PrivateLimitedCompanyLtd 2025-11-07 2026-03-31 16840429 frs-bus:FilletedAccounts 2025-11-07 2026-03-31 16840429 frs-bus:Micro-entities 2025-11-07 2026-03-31 16840429 frs-bus:AuditExempt-NoAccountantsReport 2025-11-07 2026-03-31 16840429 frs-bus:Director1 2025-11-07 2026-03-31
Registered number: 16840429
Nexgen Neurotherapy Ltd
Unaudited Financial Statements
For the Period 7 November 2025 to 31 March 2026
Lukro Ltd
21 Peckover Close
Peterborough
Cambridgeshire
PE2 8UQ
Balance Sheet
Registered number: 16840429
31 March 2026
£
Current assets 12,997
Creditors: Amounts Falling Due Within One Year (5,007 )
NET CURRENT ASSETS 7,990
TOTAL ASSETS LESS CURRENT LIABILITIES 7,990
NET ASSETS 7,990
CAPITAL AND RESERVES 7,990

Notes

1. General Information
Nexgen Neurotherapy Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16840429 . The registered office is 4th Floor Silverstream House, 45 Fitzroy Street, London, Fitzrovia, W1T 6EB.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Miss Zeba Jabeen
Director
20/09/2026